{"id":33785,"date":"2023-06-29T02:00:57","date_gmt":"2023-06-29T00:00:57","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-annonce-les-resultats-positifs-du-comite-consultatif-de-la-fda-sur-le-palovarotene-experimental-pour-la-fibrodysplasie-ossifiante-progressive\/"},"modified":"2023-06-29T02:00:57","modified_gmt":"2023-06-29T00:00:57","slug":"ipsen-annonce-les-resultats-positifs-du-comite-consultatif-de-la-fda-sur-le-palovarotene-experimental-pour-la-fibrodysplasie-ossifiante-progressive","status":"publish","type":"press_release","link":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-les-resultats-positifs-du-comite-consultatif-de-la-fda-sur-le-palovarotene-experimental-pour-la-fibrodysplasie-ossifiante-progressive\/","title":{"rendered":"Ipsen annonce les r\u00e9sultats positifs du comit\u00e9 consultatif de la FDA sur le palovarot\u00e8ne exp\u00e9rimental pour la fibrodysplasie ossifiante progressive"},"content":{"rendered":"